Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

James Russell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0827-1801; OpenAlex author ID A5048986880. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Tumor Microenvironment: Insights from Multiparametric MRI in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers18020273↗
  2. Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration thr… Co-author DOI 10.1002/prp2.898↗
  3. Predicting Gemcitabine Delivery by 18F-FAC PET in Murine Models of Pancreatic Cancer. Co-author DOI 10.2967/jnumed.120.246926↗
  4. Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma. First author DOI 10.1371/journal.pone.0231745↗
  5. In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetic… Co-author DOI 10.1007/s11307-017-1078-6↗
  6. Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. Last author DOI 10.1016/j.ijrobp.2015.06.001↗
  7. Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer. First author DOI 10.1089/cbr.2015.1869↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Laurence Humm · 7 shared papers, 2015–2026 · strength 0.88
  2. Nagavarakishore Pillarsetty · 4 shared papers, 2017–2022 · strength 0.47
  3. Louise M. Fanchon · 2 shared papers, 2020–2022 · strength 0.28
  4. Amita Shukla‐Dave · 1 shared paper, 2026 · strength 0.28
  5. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.28
  6. Ramesh Paudyal · 1 shared paper, 2026 · strength 0.28
  7. Richard Kinh Gian Do · 1 shared paper, 2026 · strength 0.28
  8. Kenneth H. Yu · 2 shared papers, 2020–2021 · strength 0.24
  9. Robin M. Kramer · 3 shared papers, 2015–2017 · strength 0.20
  10. Maeve Aine Lowery · 2 shared papers, 2015–2017 · strength 0.12
  11. Daniel L.J. Thorek · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.